Developments in Imaging Prior to Biopsy — Are Systematic Biopsies Still Required - Tom Keane

January 27, 2020

Tom Keane discusses a presentation by Laurence Klotz given at the 2019 Société Internationale d'Urologie meeting on the topic of recent developments in imaging prior to a prostate biopsy. Dr. Klotz reviewed several studies comparing MRI to transrectal biopsies' effectiveness in detecting and ruling out clinically significant cancer. He also reviewed the PRECISION trial, which compared systemic biopsies and MRI targeted biopsies, with the data showing superiority of MRI targeted biopsies in diagnosing clinically significant prostate cancer. Dr. Klotz concludes by mentioning the concerns about relying solely on targeted biopsies and MRI and provides alternatives such as the high-resolution micro-ultrasound, to assess degrees of prostate cancer.

Biographies:

Thomas E. Keane, MBBCh, FRCSI, FACS, Department of Urology, The Medical University of South Carolina, Charleston, South Carolina, USA.


Read the Full Video Transcript